Welcome to our dedicated page for FOUR LEAF ACQUISITION SEC filings (Ticker: FORLW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on FOUR LEAF ACQUISITION's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into FOUR LEAF ACQUISITION's regulatory disclosures and financial reporting.
UBS AG (London Branch) is offering $235,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of NVIDIA Corporation (NVDA).
Key commercial terms
- Issue price: $10.00 per note; minimum purchase 100 notes.
- Trade date: 3 Jul 2025; maturity: 8 Jul 2027 (≈2 years) unless called earlier.
- Contingent coupon: 15.26 % p.a. (≈$0.2543 per $10 note) paid bimonthly only if the NVDA closing price on an observation date is ≥ coupon barrier = $111.54 (70 % of initial level).
- Automatic call: triggered on any observation date (except final) if NVDA ≥ initial level = $159.34. Holder then receives principal + coupon; no further payments.
- Principal at risk: if not called and final NVDA level ≥ downside threshold = $111.54, investor receives full principal. If final level < threshold, repayment = $10 × (1 + underlying return); losses mirror NVDA decline and can reach 100 % of principal.
- Estimated initial value: $9.78, 2.2 % below issue price, reflecting fees and hedging costs.
- Secondary market: None assured; UBS Securities LLC may provide limited liquidity but may cease at any time.
Risk highlights
- Equity risk: exposure to NVDA share volatility; single-stock concentration increases idiosyncratic risk.
- Credit risk: payment obligations rely on UBS; noteholders rank as unsecured creditors.
- No guaranteed coupons; investors may receive little or no income.
- Potential loss of principal below downside threshold; contingent protection applies only at maturity.
- Liquidity and valuation risk: bid/offer spreads and lack of listing may result in material secondary-market discounts.
Investor profile: Suitable only for investors who (1) seek enhanced income, (2) can tolerate full downside exposure to NVDA below the 70 % barrier, (3) understand contingent coupon structures, and (4) are comfortable with UBS credit exposure and limited liquidity.
JPMorgan Chase Financial Company LLC is offering $500,000 principal amount of Callable Contingent Interest Notes due June 28, 2030, fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes are unsecured, unsubordinated debt linked individually (not as a basket) to the performance of the Russell 2000 Index (RTY) and the S&P 500 Index (SPX).
Contingent interest. Investors will receive a monthly Contingent Interest Payment of $5.4583 per $1,000 (equivalent to 6.55% p.a.) for each Review Date on which both indices close at or above their respective Interest Barriers (75 % of initial levels: 1,602.13875 for RTY and 4,569.12 for SPX). If either index closes below its barrier on a Review Date, no interest accrues for that period.
Issuer call feature. JPMorgan may redeem the notes in whole on any Interest Payment Date from June 30 2026 onward (excluding the final date). Early redemption pays par plus the accrued Contingent Interest Payment.
Principal repayment. At maturity, if not previously called, investors receive: (i) par plus final interest if both indices are at or above their Buffer Thresholds (85 % of initial levels: 1,815.75725 for RTY and 5,178.336 for SPX), or (ii) par reduced by the percentage decline of the lesser performing index beyond a 15 % buffer. Maximum loss equals 85 % of principal.
Key economics. • Price to public: 100 % of face; selling commission 3.75 %. • Estimated value at pricing: $946.00 per $1,000. • Minimum denomination: $1,000. • CUSIP: 48136E4C6. • Settlement: on or about June 30 2025. • Offering registered under Rule 424(b)(2) (Registration Nos. 333-270004 and 333-270004-01).
Risks. Investors bear (1) equity market risk on each index, (2) loss of up to 85 % of principal if the lesser-performing index falls below its Buffer Threshold at final valuation, (3) contingent—not guaranteed—interest, (4) issuer early-call risk, which may cap upside, and (5) credit risk of JPMorgan Financial and JPMorgan Chase & Co.
The product suits investors seeking enhanced monthly yield tied to U.S. equity indices, who can tolerate equity downside, contingent coupons, and issuer call risk over a five-year horizon.
Four Leaf Acquisition Corporation ("Four Leaf") has issued Supplement No. 1 to its June 13, 2025 Definitive Proxy Statement for the June 22, 2025 special meeting. The new disclosure amends the Risk Factors section and adds additional risk language that could materially affect the company’s ability to complete its initial business combination and maintain its Nasdaq listing.
CFIUS / foreign-ownership risk: Director Alvin Wang, resident of the PRC, controls 81.4% of Four Leaf’s Sponsor, which in turn owns about 33.2% of Four Leaf’s shares. Because of this foreign control, Four Leaf may be deemed a “foreign person” under U.S. foreign-investment rules. Any merger with a U.S. target that operates in a sensitive sector (critical technology, critical infrastructure, or significant personal-data business) could trigger a mandatory filing or full review by the Committee on Foreign Investment in the United States (CFIUS). CFIUS can delay, condition, or prohibit a transaction, potentially shrinking Four Leaf’s pool of viable targets and jeopardising timely deal completion. Failure to finish a transaction within the current deadline (June 22, 2025, or June 22, 2026 if the Extension Proposal passes) would force liquidation of the SPAC and make warrants worthless.
Nasdaq 36-month rule: Nasdaq Listing Rule IM-5101-2(b) now mandates that SPACs close a business combination within 36 months of IPO effectiveness. Four Leaf’s S-1 became effective on March 16, 2023, creating a hard deadline of March 16, 2026. The Extension Proposal seeks an Amended Termination Date of June 22, 2026 (39 months post-IPO). Nasdaq Rule 5815 (effective Oct 7, 2024) requires immediate suspension and delisting for non-compliance. Therefore, even if shareholders grant the extension, Four Leaf could still face suspension and delisting after March 16, 2026. Delisting would move trading to OTC markets and could result in reduced liquidity, “penny-stock” status, limited analyst coverage, and constrained capital-raising options.
Action items for shareholders: The record date remains unchanged; previously delivered proxies remain valid. Failure to vote or instruct brokers counts as a vote against each extension proposal. Abstentions also count as votes against the Extension Proposals but do not affect the Adjournment Proposal.
FAQ
What is the current stock price of FOUR LEAF ACQUISITION (FORLW)?
